Home » Topics » BioWorld Science

BioWorld Science
RSS

Atossa receives approval to open phase I/II study of AT-H201 in Australia

July 8, 2021

CXD-101 demonstrates promising early clinical data in its China IND program

July 8, 2021

LY-3305677 is safe and shows body weight-lowering effect in FIH trial

July 8, 2021

To close or not to close: Astrocytes influence brain plasticity by controlling critical period

July 8, 2021

Researchers at University of Oxford initiate phase I study of HIVconsvX vaccine

July 8, 2021

Centivax patents CR-3022-derived antibodies for SARS-CoV-2

July 8, 2021

Chiesi Farmaceutici synthesizes new LPAR2 antagonists

July 8, 2021

Shaanxi Synthetic Pharmaceutical identifies new antibacterials

July 8, 2021

Roche discloses BRAF mutant inhibitors

July 8, 2021

Chinese researchers patent claudin 18.2-targeting ADCs

July 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
An early stage 85% remissions rate in AML drives Aptevo’s stock surge
BioWorld
An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...
BIO 2025: Makary lays out FDA’s path, launches pilot review program
BioWorld
On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
Alphadesign: AI creating proteins from scratch
BioWorld Science
The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to make it possible to design de novo...